Literature DB >> 10888702

Evidence-based treatment of systemic vasculitis.

D Jayne1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10888702     DOI： 10.1093/rheumatology/39.6.585

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  15 in total

Review 1.  EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.

Authors:  Bernhard Hellmich; Oliver Flossmann; Wolfgang L Gross; Paul Bacon; Jan Willem Cohen-Tervaert; Loic Guillevin; David Jayne; Alfred Mahr; Peter A Merkel; Heiner Raspe; David G I Scott; James Witter; Hasan Yazici; Raashid A Luqmani
Journal:  Ann Rheum Dis       Date:  2006-12-14       Impact factor: 19.103

2.  Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis.

Authors:  David R W Jayne; Annette N Bruchfeld; Lorraine Harper; Matthias Schaier; Michael C Venning; Patrick Hamilton; Volker Burst; Franziska Grundmann; Michel Jadoul; István Szombati; Vladimír Tesař; Mårten Segelmark; Antonia Potarca; Thomas J Schall; Pirow Bekker
Journal:  J Am Soc Nephrol       Date:  2017-04-11       Impact factor: 10.121

3.  CD4+ T cells sensitized by vascular smooth muscle induce vasculitis, and interferon gamma is critical for the initiation of vascular pathology.

Authors:  Dana Carina Baiu; Matyas Sandor; Michael Hart
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

Review 4.  Pulmonary vasculitis.

Authors:  Kevin K Brown
Journal:  Proc Am Thorac Soc       Date:  2006

Review 5.  Cutaneous vasculitis.

Authors:  Samina Hayat; Seth Mark Berney
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

6.  Autoantibodies to vascular smooth muscle are pathogenic for vasculitis.

Authors:  Dana Carina Baiu; Brittany Barger; Matyas Sandor; Zsuzsa Fabry; Michael Noel Hart
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

7.  Factors associated with major infections in patients with granulomatosis with polyangiitis and systemic lupus erythematosus treated for deep organ involvement.

Authors:  Muir Morton; Sarah Edmonds; Aislinn M Doherty; Ajay Dhaygude; Matthew Helbert; Mike Venning
Journal:  Rheumatol Int       Date:  2011-11-02       Impact factor: 2.631

8.  Glucocorticoid Therapy in ANCA Vasculitis: Using the Glucocorticoid Toxicity Index as an Outcome Measure.

Authors:  Lauren Floyd; Adam Morris; Miland Joshi; Ajay Dhaygude
Journal:  Kidney360       Date:  2021-04-20

Review 9.  [Interstitial lung disease].

Authors:  H-P Hauber; D Kirsten
Journal:  Z Rheumatol       Date:  2009-10       Impact factor: 1.372

10.  Diffuse alveolar hemorrhage.

Authors:  Moo Suk Park
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.